NCT01704196 - A Multi-Center Trial of Nepicastat for Cocaine Dependence | Biotech Hunter

Enrollment

179

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

December 31, 2014

Conditions

Cocaine Dependence

Interventions

DRUG

Nepicastat

120 mg of active drug and 100mg of riboflavin daily for 11 weeks or matching placebo containing 100mg of riboflavin daily for 11 weeks.

DRUG

Placebo

Trial Locations (10)

Columbia University Medical Center, New York

University of Pennsylvania - Treatment Research Center, Philadelphia

Mountain Manor Treatment Center at Baltimore, Baltimore

Cincinnati Addiction Research Center, Cincinnati

Michael E. DeBakey VA Medical Center, Houston

VA Medical Center - Denver, CO, Denver

George E. Wahlen VA Medical Center, Salt Lake City

Pacific Institute for Research and Evaluation, Albuquerque

Matrix Institute on Addictions, Los Angeles

VA San Diego Healthcare System, San Diego

All Listed Sponsors

lead

National Institute on Drug Abuse (NIDA)

NIH